Impact of COVID-19 on the delivery of STBBI-related services in Canada, including harm reduction services

Download the alternative format
(1.09 MB, 1 page)

Organization: Public Health Agency of Canada

Date published: 2022-03-03

Cat.: HP40-299/2021E-PDF

ISBN: 978-0-660-40858-3

Pub.: 210416

Findings from the Survey on the impact of COVID-19 on the delivery of transmitted and blood-borne infection (STBBI) prevention, testing and treatment in Canada, including harm reduction services, 2020.

The Public Health Agency of Canada conducted an online survey in November and December 2020 to better understand how the COVID-19 pandemic has affected the ability of healthcare service providers to deliver STBBI prevention, testing and treatment services, including harm reduction and drug treatment services, in Canada.

Who participated

Size of city or town where organization is located

Services provided

Organization type

Designated as an essential service

Received funding to support response to COVID-19

Since the start of the COVID-19 pandemic

STBBI service providers demonstrated resilience and innovation by developing new delivery models that met the challenges created by the pandemic

Acknowledgements

The authors gratefully acknowledge the valuable input and contribution of the survey participants. For more information, look for our Data Blog and our full-length report titled: Findings from the Survey on the Impact of COVID-19 on the delivery of STBBI prevention, testing and treatment in Canada, including harm reduction services, 2020.

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: